comparemela.com

Page 6 - Consilient Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders

Aeterna Zentaris Announces Virtual 2021 Annual Meeting of Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

3 Penny Stocks to Watch During the Last Week of April

Which Penny Stocks Are Investors Watching Today? As another week of trading penny stocks commences, the options for making your watchlist are endless. Because there are thousands of penny stocks to watch, investors need to be picky when looking for the right one to buy. Now, it’s not enough to just find penny stocks due to an interesting business model. Rather, we have to consider the current trends, speculative factors affecting a company, and its fundamentals.  Any pro-trader will tell you that research is the most important part of creating a penny stock watchlist. And, that isn’t any coincidence. While knowing your stuff is important, investors need to understand what factors will impact penny stocks short term and long-term prices. Right now, there are some extraordinary aspects to consider. This includes the effects of the pandemic, potential long-term inflation in the U.S. economy, and lower than average trading volume.  [Read More] Trading Penny Stocks This

Diurnal (AIM:DNL) | RNS | Diurnal Group PLC - Proposed Placing, Subscription and Open Offer

REPUBLIC OF SOUTH AFRICA OR JAPAN. NEITHER THIS ANNOUNCEMENT NOR ANYTHING CONTAINED HEREIN SHALL FORM THE BASIS OF, OR BE RELIED UPON IN CONNECTION WITH, ANY OFFER OR COMMITMENT WHATSOEVER IN ANY JURISDICTION.   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU AS IT FORMS PART OF THE LAW OF ENGLAND AND WALES BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. IN ADDITION, MARKET SOUNDINGS WERE TAKEN IN RESPECT OF THE MATTERS CONTAINED IN THIS ANNOUNCEMENT, WITH THE RESULT THAT CERTAIN PERSONS BECAME AWARE OF SUCH INSIDE INFORMATION. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

Aeterna Zentaris Continues to Demonstrate Pipeline Expansion – Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism

Aeterna Zentaris Continues to Demonstrate Pipeline Expansion – Announces the Initiation of Its Preclinical Program for the Potential Treatment of Primary Hypoparathyroidism March 11, 2021 08:05 ET | Source: Aeterna Zentaris Inc Aeterna Zentaris Inc Montreal CANADA – Company obtains an exclusive license from The University of Sheffield, UK to intellectual property relating to parathyroid hormone (PTH) fusion polypeptides covering the field of human use which will initially be studied by Aeterna for the potential therapeutic treatment of primary hypoparathyroidism – Continued execution on growth strategy to establish a diversified, yet focused, pipeline of development assets leveraging the Company’s expertise and experience CHARLESTON, S.C., March 11, 2021 (GLOBE NEWSWIRE) Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) through its wholly-owned subsidiary Aeterna Zentaris GmbH, (“Aeterna” or the “Company”)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.